American Society of Hematology

SHERPA: Blue

People

  1. Sadelain
    Sadelain
  2. Park
    Park
  3. Wang
    Wang
  4. Curran
    Curran
  5. Bernal
    Bernal
  6. Kernan
    Kernan
  7. O'Reilly
    O'Reilly
  8. Stefanski
    Stefanski
  9. Scheinberg
    Scheinberg
  10. Giralt
    Giralt

Groups

  1. Adult Leukemia (45)
  2. Center for Hematologic Malignancies (45)
  3. Department of Medicine (45)
  4. GSK Faculty (45)
  5. Hematologic Malignancies Research (45)
  6. Hematologic Malignancies, Division of (45)
  7. Sloan Kettering Institute Faculty (45)
  8. Molecular Pharmacology and Chemistry Program Faculty (40)
  9. Nursing (15)
  10. Pediatrics, Department of (13)
Search Within
  1. "Sloan Kettering Institute Faculty"
  2. "Renier Brentjens"
Formats
  1. Meeting Abstract (37)
  2. Journal Article (8)
Groups
  1. Adult Leukemia (45)
  2. Center for Hematologic Malignancies (45)
  3. Department of Medicine (45)
  4. GSK Faculty (45)
  5. Hematologic Malignancies Research (45)
  6. Hematologic Malignancies, Division of (45)

More Groups

People
  1. Renier Brentjens (45)
  2. Michel Sadelain (35)
  3. Isabelle Riviere (29)
  4. Jae Park (25)
  5. Xiuyan Wang (19)
  6. Kevin Curran (12)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2020 (1)
  4. 2019 (4)
  5. 2018 (3)
  6. 2017 (1)

More Years

Publications
  1. Blood (44)
  2. Blood Advances (1)

Results (45)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies
    Meeting Abstract

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Wudhikarn, K.; Flynn, J. R.; Rivière, I.; Gönen, M.; Wang, X.; Senechal, B.; Curran, K. J.; Roshal, M.; Maslak, P. G.; Geyer, M. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory B-cell malignancies
    Meeting Abstract

    Park, J. H.; Riviere, I.; Sikder, D. S.; Bermudez, V. P.; Senechal, B.; Wang, X.; Auchincloss, T. H.; Diamonte, C.; Halton, E.; Palomba, M. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical factors associated with improved survival following allogeneic HSCT after CD19 CAR therapy in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J. H.; Flynn, J.; Gonen, M.; Bernal, Y.; Diamonte, C.; Halton, E.; Wang, X.; Riviere, I.; Sadelain, M.; Brentjens, R. J.
    Blood (2019)

    Fulltext@MSK | Save
  • Optimal dual-targeted CAR construct simultaneously targeting BCMA and GPRC5D prevents BCMA-escape driven relapse in multiple myeloma
    Meeting Abstract

    Fernandez de Larrea, C.; Staehr, M.; Lopez, A.; Chen, Y.; Purdon, T. J.; Ng, K. Y.; Wendel, H.; Brentjens, R. J.; Smith, E. L.
    Blood (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
    Journal Article

    Sauter, C. S.; Senechal, B.; Rivière, I.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Singh, A. N.; Szenes, V. Z.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A phase I first-in-human clinical trial of CD19-targeted 19-28z/4-1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter's transformation
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Batlevi, C. L.; Riviere, I.; Wang, X.; Senechal, B.; Furman, R. R.; Bernal, Y.; Hall, M.; Pineda, J.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Intestinal microbiota composition prior to CAR T cell infusion correlates with efficacy and toxicity
    Meeting Abstract

    Smith, M.; Littmann, E. R.; Slingerland, J. B.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Schluter, J.; Park, J. H.; O'Cearbhaill, R.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save